Rabesta 20

Rabesta 20



Stallion Labs




Macropharma Corp
Concise Prescribing Info
Rabeprazole Na
Active duodenal ulcer, benign gastric ulcer, Zollinger-Ellison syndrome & ulcerative or erosive GERD.
Dosage/Direction for Use
Benign gastric ulcer 20 mg daily in the morning for 6 wk, continued for further 6 wk if not fully healed. Duodenal ulcer 20 mg daily in the morning for 4 wk, continued for further 4 wk if not fully healed. Ulcerative or erosive GERD 20 mg once daily for 4-8 wk. Maintenance: 10-20 mg daily. Symptomatic treatment in the absence of esophagitis: 10 mg daily for up to 4 wk, then 10 mg daily when required. Duodenal & benign gastric ulcer associated w/ H. pylori 20 mg + clarithromycin 500 mg & amoxicillin 1 g for 7 days, doses to be taken bid.
May be taken with or without food: Swallow whole, do not chew/crush.
Hypersensitivity to rabeprazole & substituted benzimidazole.
Special Precautions
Hepatic impairment. Monitor gastric malignancy. May cause allergic type reactions (including bronchial asthma) due to tartrazine content. Pregnancy & lactation.
Adverse Reactions
Diarrhea, nausea, headache, vomiting, abdominal pain, dizziness, flatulence, constipation, dyspepsia, flu-like syndrome, insomnia, back pain, cough, rhinitis, pharyngitis, rash.
Drug Interactions
Risk of abnormal bleeding due to increased INR & prothrombin time w/ warfarin. Decreased ketoconazole levels. Increased trough levels of digoxin.
MIMS Class
Antacids, Antireflux Agents & Antiulcerants
ATC Classification
A02BC04 - rabeprazole ; Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
Rabesta 20 EC tab 20 mg
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in